Eleventh Circuit Court Upholds Dismissal of CoolSculpting Lawsuit: A Case Study on Consumer Protection and Informed Decision Making

August 5, 2023

Zeltiq Aesthetics Inc., the manufacturer of the CoolSculpting fat reduction treatment, has been at the center of a legal dispute regarding allegations that their product can enlarge fat tissue instead of reducing it. In a recent ruling, the Eleventh Circuit upheld the dismissal of a lawsuit against Zeltiq, stating that the company had adequately warned medical professionals about the potential risks associated with the treatment.

The court's decision highlighted that Zeltiq had issued clear warnings to medical professionals, including information about the possibility of Paradoxical Adipose Hyperplasia (PAH), a condition in which the targeted fat tissue enlarges. These warnings were provided through user manuals, training materials, and consent forms signed by patients.

In this particular case, the plaintiff, Terrance Cates, had received CoolSculpting treatment from a registered nurse practitioner in 2018. Subsequently, he developed a visible mass in his lower stomach and hips. Cates asserted multiple claims, including failure to warn, design defect, negligence, negligent misrepresentation, and fraudulent misrepresentation and concealment.

The court dismissed Cates' failure to warn and design defect claims, emphasizing that Zeltiq's obligation was to inform the medical professional performing the treatment, rather than directly warning the patient. The court also noted that Cates failed to demonstrate a defect in the CoolSculpting device, as he only pointed to a known, but rare, side effect.

Zeltiq's CoolSculpting system gained FDA clearance in 2010 and is a non-surgical fat reduction method that targets specific body areas by freezing away fat. It is primarily administered by medical professionals in dermatology offices, plastic surgery clinics, and medical spas.

It is worth noting that this is not the first time Zeltiq has faced allegations regarding the CoolSculpting device. In a separate case, Canadian model Linda Evangelista sued the company for damages after experiencing PAH and scarring following multiple treatments. However, the details of that lawsuit were voluntarily dismissed in July 2022.

Legal representatives for both Terrance Cates and Zeltiq declined to comment on the recent ruling.

With the right information, patients can take a proactive approach to their healthcare and ensure that they are receiving the best possible care. Together, we can work to make sure our clients receive the justice they deserve. If you or anyone you know has been affected by coolsculpting complications, please reach out to Jason J. Joy & Associates at 713-221-6500. Thank you for entrusting us to join your fight. 


While this article provides general legal information, it does not constitute legal advice. The best way to get guidance on your specific legal issue is to contact a lawyer.


Contact Us

By submitting this form you agree to receive text messages.

By Jason Joy Law • September 21, 2026
Meta, the company behind Facebook and Instagram, is on trial again in New Mexico. This month a Santa Fe courtroom began hearing State of New Mexico v. Facebook, Inc., a case that goes back to the Cambridge Analytica data scandal of the 2016 election. The trial comes only weeks after a New Mexico court entered a $942 million judgment against Meta in a separate child-safety case. The two cases involve different claims, but both put Meta's conduct, and what it has told the public, under scrutiny. What the Cambridge Analytica Trial Is About New Mexico's Attorney General alleges that Facebook violated the state's Unfair Practices Act. The case centers on a personality quiz app that, according to the state, was used to harvest information from approximately 87 million Facebook profiles. That figure does not mean 87 million people took the quiz. It refers to the Facebook profiles whose information may have been improperly collected and shared, most of which belonged to the friends of people who used the app. New Mexico alleges that Cambridge Analytica, a political consulting firm, used Facebook profile data in connection with targeted political messaging during the 2016 election, and that about 350,000 New Mexicans were affected. Former Attorney General Hector Balderas filed the case in 2021. Current Attorney General Raúl Torrez is now bringing it to trial before Judge Francis Matthew in the First Judicial District Court in Santa Fe. The trial is expected to last about four weeks, and Courtroom View Network is broadcasting it gavel to gavel. Meta rejects the allegations. In court, the company has argued that the lawsuit rests on claims that are "settled or debunked." Meta has also accused the Attorney General's office of trying to limit its First Amendment rights. The trial is ongoing and no verdict has been reached. The claims described above remain allegations that Meta disputes. A Separate Case: New Mexico's Child-Safety Judgment Against Meta The Cambridge Analytica case is separate from litigation involving alleged harms to young social media users. It concerns Facebook's handling of user data and representations about its privacy practices. Earlier this year, however, New Mexico also pursued a separate case against Meta involving allegations about the safety and design of Facebook and Instagram for minors. New Mexico obtained a jury verdict and final judgment against Meta in that separate child-safety case. In March 2026, a jury ordered Meta to pay a $375 million civil penalty. On August 7, 2026, the court entered an additional $567 million judgment tied to the youth mental health crisis, bringing the total to $942 million. In that case, the state alleged that Meta built products it knew would fuel addiction and deepen a youth mental health crisis, then misled parents about the risks. The court also ordered Meta to change how its platforms treat minors for five years. The required changes include: Stronger age verification and more protection for teen accounts No overnight push notifications for users under 18 Hidden "like" counts by default Mandatory time-use limits for minors Clear disclosures about the risks of using the platforms Several of these changes aim at the same design features that keep young users scrolling late into the night. Why This Matters for Your Family It's important to be clear about what the Cambridge Analytica trial is and isn't. It is a privacy, data-use and consumer-protection case. It does not concern, and will not decide, whether social media use caused harms such as depression, eating disorders or self-harm. Those questions are being raised in separate cases, including New Mexico's child-safety case and lawsuits filed by families across the country. Many parents don't learn how much social media has affected their child until the harm is serious. Families have described: Depression and severe anxiety Body dysmorphia Eating disorders, including anorexia and bulimia Suicidal thoughts or self-harm Compulsive use that a child can't control If you or your child used Instagram, Facebook, TikTok, Snapchat or YouTube heavily as a minor and later developed any of these conditions, you may have options. Lawsuits across the country are now testing whether social media companies can be held accountable for designing products that harm young users. How Jason Joy Law Can Help We represent families and young adults harmed by social media platforms. We know that many parents worry about their child's privacy when they reach out, and we treat every conversation with care and discretion. To learn more about who may qualify and what these cases involve, visit our Social Media Harm page , or call (888) 241-7367 for a free, confidential case evaluation. Meeting these criteria does not guarantee representation or compensation. Each case is evaluated on its individual merits. Sources David Siegel, " Facebook Faces Cambridge Analytica Scandal Trial in New Mexico — Watch Gavel-to-Gavel via CVN ," Courtroom View Network, September 9, 2026. New Mexico Department of Justice, " Court Orders Meta to Pay $942 Million and Overhaul Protections for Children on Facebook and Instagram in Landmark New Mexico Ruling ," August 7, 2026.
By Rebecca Rivera • December 9, 2025
As reported in the Washington Post December 5th, 2025 by Amudalat Ajasa A prominent scientific journal, Regulatory Toxicology and Pharmacology, has retracted a widely cited 2000 study that previously concluded the active ingredient in Roundup, glyphosate, posed no cancer risk to humans. The retraction was initiated after evidence emerged suggesting the study was heavily influenced by the herbicide's seller, Monsanto (now owned by Bayer), in an apparent effort to disguise potential health risks. Specific concerns cited by the journal include the strong possibility that Monsanto employees contributed to the writing without proper acknowledgment, that the authors may have received undisclosed payments from the company , and that the findings were based solely on unpublished Monsanto studies. This misconduct, discovered through internal company emails during federal litigation, is significant because the faulty research served as a bedrock for regulatory decisions regarding glyphosate for decades. Summary of Alleged Faulty Study and Monsanto's Influence The Study and Its Conclusion: The retracted paper, published in 2000, was a "bedrock study" that concluded: "under present and expected conditions of new use, there is no potential for Roundup herbicide to pose a health risk to humans." The Retraction: The scientific journal retracted the study due to a loss of confidence in its results and conclusions, citing the need to "maintain the integrity of the journal." Evidence of Undisclosed Influence: The co-editor in chief cited evidence suggesting that Monsanto employees "may have contributed to the writing of the article without proper acknowledgment as co authors." Undisclosed Payments: The retraction also noted that the study's authors may have been paid by Monsanto without disclosing it . Basis of Findings: The journal stated that the study's findings about cancer risk were "solely based on unpublished studies from Monsanto." Discovery of Influence: Monsanto's influence over the study was reportedly discovered through internal emails released during federal litigation against the company in 2017. Impact: The study "had a significant impact on regulatory decision-making regarding glyphosate and Roundup for decades," and was one of the most-cited papers on glyphosate safety, underpinning federal regulations for the pesticide. The Environmental Protection Agency (EPA) even cited it in its 2016 review of glyphosate. Context and Aftermath Bayer's Defense: Bayer (which acquired Monsanto in 2018) defended the chemical's safety and argued that Monsanto's involvement was appropriately cited in the acknowledgments, stating that glyphosate is the most extensively studied herbicide and that the "vast majority of published studies on glyphosate had no Monsanto involvement." Regulatory Stance: The EPA stated the retraction would not affect its current stance —which is that glyphosate is "not likely to be carcinogenic to humans"—because the agency does not directly rely on review articles like this one, but uses them to find other relevant individual studies. Litigation: Bayer has spent approximately $10 billion to settle lawsuits arguing the company did not warn customers about the negative health impacts of using Roundup. Read the full article in the Washington Post
By Rebecca Rivera • November 14, 2025
In this series premiere episode, Founder & President of SOSCSA, Child Sexual Abuse Survivor & BSA Bankruptcy Claimant, Curtis Garrison interviews attorney Jason J Joy for an update on the BSA bankruptcy and discussing childhood abuse litigation for which Jason is an outspoken and experienced advocate. Jason's firm is actively litigating cases for many clients his law firm represents. This podcast is recommended for clients already represented, and for those who are still contemplating coming forward to establish a claim. Topics covered in this episode: Recent BSA Bankruptcy Trust report Lajun Claimants (Guam) v. Boy Scouts of America and their recent Petition For A Writ Of Certiorari to the U.S. Supreme Court The 1.5% initial payment, possible second payment time / total percentage Future Claims, BSA Councils, BSA Charters (churches, schools, etc) which there are over 100,000 entities possibly getting free of liability Mixed Claims explained We did not vote for this plan, they promised we would be paid in “Paid in Full” Plans to file an Amicus Brief Statute of Limitations